Brind.

CEO Jim Davis of Quest Diagnostics commented on the trend of increased test ordering.

1 report, 1 independent Updated Jul 23

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Jim Davis Quest Diagnostics

Keep exploring

The entities involved

Jim Davis
Nothing else this week.
Quest Diagnostics
medical research company
- Market share and investment focus comparison between Quest Diagnostics and GeneDx Holdings Corp. is underway.Mon 12:54
- Quest Diagnostics made required filings with the Securities and Exchange Commission regarding share holdings on June 18, 2026.Mon 10:44

Coverage

Newest first; wire copies grouped

Jul 23StockStoryDGX Q2 Deep Dive: Acquisitions, Advanced Diagnostics, and Utilization Trends Drive Growth Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q2 CY2025 results exceeding the market’s